That depends, as suggested by results of the CASTLE-AF study, presented at ESC Congress 2017, in Barcelona, Spain.
Diagnosis of atrial fibrillation via handheld iECG monitor looks promising but can we pay for it yet?
A 56-year-old man comes to your office for two “spells” he’s had in the past three days, each lasting approximately 20-30 seconds before resolving spontaneously. The first was blurry vision in both eyes without other vision changes.
Mr Smith is 66-years-old. How would you treat his arrhythmia? What would you choose for anticoagulation?
Digoxin is used in nearly 30% of patients with AF but has never been studied for safety/efficacy in this population, until now.
Is exercise safe in HF patients who have AF? Results of the HF-ACTION study are summarized in this short slide show.
A study of a global registry finds that prescriptions for direct oral anticoagulants have now surpassed those for VKAs. What do you Rx?
Patients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start.
In these complicated patients, should warfarin or a novel oral anticoagulant be chosen for stroke prevention?
Is aspirin safe as antithrombotic therapy in pregnancy? Is electrocardioversion first-line treatment? Get the answers and other reminders, here.